Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 3/20 | 0.52 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.52 |
| ▸ | CDK9 | P50750 | 2/20 | 0.52 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.52 |
| ▸ | CDK14 | O94921 | 12/20 | 0.49 |
| ▸ | CCNY | Q8ND76 | 12/20 | 0.49 |
| ▸ | CDK2 | P24941 | 4/20 | 0.49 |
| ▸ | CDK4 | P11802 | 2/20 | 0.49 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.49 |
| ▸ | GSK3B | P49841 | 2/20 | 0.49 |
| ▸ | CASK | O14936 | 1/20 | 0.49 |
| ▸ | CDKL5 | O76039 | 1/20 | 0.49 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | MAK | P20794 | 1/20 | 0.49 |
| ▸ | CDK11B | P21127 | 1/20 | 0.49 |
| ▸ | CCND1 | P24385 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13934402 | 0.91 | CDK5 (0.46) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| SCHEMBL8262984 | 0.88 | CDK14 (0.49) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| At-7519 SCHEMBL955568 | 0.88 | CDK5 (0.67) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| SCHEMBL8262439 | 0.87 | CDK14 (0.46) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| SCHEMBL1286693 | 0.87 | CDK2 (0.50) | CDK2CCNA1CCNA2DYRK1AGSK3B | |
| SCHEMBL13993691 | 0.87 | CDK5 (0.52) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| At-7519 SCHEMBL31046986 | 0.87 | CDK5 (0.66) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| At-7519 SCHEMBL953647 | 0.87 | CDK5 (0.66) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| SCHEMBL8261517 | 0.87 | CDK5 (0.48) | CDK5CCNT1CDK9CDK5R1CDK14 | |
| SCHEMBL8263063 | 0.87 | CDK14 (0.45) | CDK5CCNT1CDK9CDK5R1CDK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306069-A1 | Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S | ASTEX THERAPEUTICS LIMITED (UK) | 2008-12-11 | — | — | US | disclosed |
| US-20080306069-A1 | Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S | ASTEX THERAPEUTICS LIMITED (UK) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306069-A1 | Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S | GSK3A, CDK11A, CDK1 | CDK5 39/4885CCNT1 48/4885CDK9 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.